A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)
Clinical trial NCT03474107 · COMPLETED
Trial details
- NCT number
- NCT03474107
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-27
- Primary completion
- 2020-07-15
- Enrollment
- 608
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.